Date: 2014-07-24
Type of information: Company acquisition
Acquired company: Unisensor (Denmark)
Acquiring company: Philips (The Netherlands)
Amount: undisclosed
Terms: * On July 24, 2014, Royal Philips announced that it has signed an agreement to acquire Unisensor, an innovator in the field of optical analysis of fluids for diagnostic applications in health care, as well as other industries. Upon closing of the transaction, which is expected in the third quarter of 2014 and subject to certain closing conditions, Unisensor, headquartered in Allerød, Denmark, will become part of Philips’ Healthcare Incubator within Philips Innovation, Group & Services. Financial terms of the acquisition were not disclosed.
Details: The Unisensor technology and team will strengthen Philips’ innovation capabilities in the field of patient sample analysis such as blood testing for applications in oncology therapy monitoring. These innovations aim to enhance patient triage and treatment at the point-of-care, thereby helping to improve patient care at a lower cost. The acquisition of Unisensor will expand Philips\' technology platforms for miniaturized, mobile diagnostic solutions. Unisensor’s current product line includes oCelloScope, an analytical instrument that is, amongst other applications, used within cancer cell studies on a research application basis. The company has partnerships with leading companies in animal health and water analysis, which Philips intends to continue.
Related: Diagnostics
